China Pharmaceuticals (600056.SH): Pemabate chemical raw materials approved for marketing

Zhitongcaijing · 6d ago

Zhitong Finance App News, China Pharmaceutical (600056.SH) issued an announcement. Recently, Tianfang Pharmaceutical Co., Ltd. (“Tianfang Pharmaceutical”), a wholly-owned subsidiary of the company, received the Pemabate “Chemical Ingredient Marketing Application Approval Notice” approved and issued by the State Drug Administration. The drug is used for adult patients with non-familial hypertriglyceridemia (HTG) on the basis of diet control to reduce triglyceride (TG) levels.